WO2023214431 - A PHARMACEUTICAL COMPOSITION OF PITOLISANT HYDROCHLORIDE AND THEIR PROCESS FOR THE PREPARATION
National phase entry is expected:
Publication Number
WO/2023/214431
Publication Date
09.11.2023
International Application No.
PCT/IN2023/050427
International Filing Date
04.05.2023
Title **
[English]
A PHARMACEUTICAL COMPOSITION OF PITOLISANT HYDROCHLORIDE AND THEIR PROCESS FOR THE PREPARATION
[French]
COMPOSITION PHARMACEUTIQUE DE CHLORHYDRATE DE PITOLISANT ET SON PROCÉDÉ DE PRÉPARATION
Applicants **
MSN LABORATORIES PRIVATE LIMITED, R&D CENTER
Inventors
NITHIYANANDAM, Ravi Kumar
THOTA, Siva Prasad
Priority Data
202241025983
04.05.2022
IN
202241056548
01.10.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2096 | |
| EPO | Filing, Examination, Granting | 11761 | |
| Japan | Filing, Examination, Granting | 2139 | |
| South Korea | Filing, Examination, Granting | 1998 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
23,334
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to a pharmaceutical composition compositions, that comprise amorphous form of pitolisant or pharmaceutically acceptable salts thereof, which is efficacious, chemically stable and physiologically balanced for safety and efficacy. The said invention is used for treatment of excessive daytime sleepiness (EDS) and cataplexy in adult patients with narcolepsy. Further the invention relates to the process for preparation of said pharmaceutical composition.[French]
La présente invention concerne une composition pharmaceutique comprenant une forme amorphe de pitolisant ou de sels pharmaceutiquement acceptables de celui-ci, qui est efficace, chimiquement stable et physiologiquement équilibrée aux fins de sécurité et d'efficacité. Ladite invention est utilisée pour le traitement d'une somnolence diurne excessive (SDE) et d'une cataplexie chez des patients adultes atteints de narcolepsie. L'invention concerne en outre le procédé de préparation de ladite composition pharmaceutique.